MBX Biosciences, Inc. MBX Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s payments of stock issuance costs?
- MBX Biosciences, Inc. (MBX) reported payments of stock issuance costs of $378K in Q1 2026.
- What does payments of stock issuance costs mean?
- This represents the direct costs incurred in connection with the issuance of equity, such as underwriting fees, legal expenses, and accounting fees. These costs are typically deducted from the gross proceeds of the offering. Monitoring these expenses helps evaluate the efficiency of the company's capital-raising activities.